U.S. federal trademark · Serial No. 86845555
Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders
Pharmaceutical preparations and drug development services for developing drug treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.